GLP-1 receptor agonists, including semaglutide and tirzepatide, have revolutionized the approach to weight loss
Safety Considerations and When to Contact Your GP GLP-1 medications are generally well-tolerated , but understanding potential adverse effects and safety signals is essential for all patients
GLP-1 medications begin working immediately with most patients seeing steady weight loss over time
Water and sweat can loosen the patch, and patch ingredients may be unsafe during physical activity
Thyroid labs (TSH, Free T4, Free T3) should be checked every 68 weeks when starting or adjusting GLP-1 or thyroid medications
For treatment through the NHS, patients are typically required to have: A Body Mass Index (BMI) of 40 or above At least four of the following weight-related conditions High blood pressure (hypertension) Heart disease (cardiovascular disease) Abnormal blood fats (dyslipidemia) Obstructive sleep apnea Type 2 diabetes Must have tried other weight loss methods first Women make up the majority of Mounjaro users in the UK at more than three-quarters (77.6%), while men account for 22.4% of users